MADRIGAL PHARMACEUTICALS, INC. ($MDGL)
Filing Information
| Accession Number | 0001628280-26-015763 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
9,399
Total Value
$155,498.40
P&L
+inf% (+$3,987,645.24)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Common Stock | โ | Mar 4, 2026 | Grant/Award | 4,017 | $0.00 | $0.00 | 12,498 | Direct | โ | View Details | |
General Counsel | Common Stock | โ | Mar 6, 2026 | Sale | 360 | $431.94 | $155,498.40 | 12,138 | Direct | โ | View Details | |
General Counsel | Stock Option (Right to Buy) | Derivative | Mar 4, 2026 | Grant/Award | 5,022 | $0.00 | $0.00 | 5,022 | Direct | โ | View Details |